We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MIATK:BISTMIA Teknoloji AS Analysis

Data as of 2026-06-11 - not real-time

TRY 46.90

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

MIA Teknoloji is trading above its short‑term and long‑term moving averages, indicating a technical bullish bias, yet the MACD histogram is negative and the RSI sits near the midpoint, suggesting limited upside momentum. Price action in May has been erratic, with daily moves ranging from modest gains to sharp declines and volumes spiking on the larger swings, reflecting the high 30‑day volatility flag. The company’s fundamentals are weak: earnings are negative, cash flow is insufficient to cover debt, and the discounted cash flow model values the stock far below the current market level, pointing to a substantial overvaluation gap. Balance sheet stress is evident from a debt load that dwarfs equity and a negative free cash flow trend, raising concerns about financial sustainability. Recent news headlines show pronounced price volatility without any clear catalyst, reinforcing the view that market sentiment is driven more by short‑term trading dynamics than by underlying business improvements. Given the combination of technical bullishness, severe valuation disconnect, and financial fragility, the outlook leans toward caution, with any upside likely limited to speculative traders capitalizing on momentum rather than long‑term investors seeking value.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Technical bullish alignment with moving averages
  • Bearish MACD signal and high price volatility
  • Absence of earnings momentum

Medium Term

1–3 years
Neutral
Model confidence: 4/10

Key Factors

  • Continued overvaluation relative to DCF
  • Weak balance sheet and debt burden
  • Sector stability but limited growth prospects

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Fundamental disconnect with negative earnings and cash flow
  • Significant valuation gap suggesting price correction
  • Financial risk from high leverage and negative free cash flow

Key Metrics & Analysis

Financial Health

Revenue Growth-26.00%
Profit Margin-39.67%
ROE-18.19%
ROA5.08%
Debt/Equity29.23
P/B Ratio4.2
Op. Cash FlowTRY433.7M
Free Cash FlowTRY-1651751040
Industry P/E35.2

Technical Analysis

TrendBullish
RSI48.8
SupportTRY 42.14
ResistanceTRY 57.85
MA 20TRY 48.74
MA 50TRY 44.64
MA 200TRY 40.34
MACDBearish
VolumeStable
Fear & Greed Index81.75

Valuation

Fair ValueTRY 5.67
GradeOvervalued
TypeValue

Risk Assessment

Beta0.05
Volatility85.69%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskHigh
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.